Devices
![Johnson & Johnson's Ottava Surgical Robot Set for U.S. Clinical Trials](https://pharmtales.com/wp-content/uploads/2023/11/JJ-MedTech-Plans-U.S.-Clinical-Trials-for-Ottava-Surgical-Robot-in-Late-2024.jpg)
J&J MedTech Plans US Clinical Trials for Ottava Surgical Robot in Late 2024
Anika Sharma
Johnson & Johnson MedTech has set a new timeline for the development of its highly anticipated entry into the competitive ...
![Zimmer Biomet's Q3 Sales Growth and CEO Tornos' Vision for Innovation](https://pharmtales.com/wp-content/uploads/2023/11/Zimmer-Biomet-Sees-Steady-Q3-Sales-Growth-New-CEO-Tornos-Unveils-Vision-for-an-Innovation-Journey.jpg)
Zimmer Biomet Sees Steady Q3 Sales Growth, New CEO Tornos Unveils Vision for an ‘Innovation Journey’
Anika Sharma
Zimmer Biomet’s executive branch experienced significant changes in the third quarter, but these transitions haven’t derailed the company’s steady growth ...
![3M CEO talks healthcare spinoff, revenue drop | Pharma News](https://pharmtales.com/wp-content/uploads/2023/10/3M-CEO-updates-on-healthcare-spinoff-amid-revenue-decline.jpg)
3M CEO updates on healthcare spinoff amid revenue decline
Anika Sharma
In a recent company update, 3M has provided insights into the status of its long-anticipated healthcare business spinout, indicating that ...